Tuaor oxygenation: A matter of supply and demand

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 741-750

  Gulledge, Christopher J ^a   Dewhirst, Maak W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Tumor blood flow; Tumor metabolism; Tumor oxygenation

Indexed keywords

ARTICLE; CELL PROLIFERATION; ENERGY METABOLISM; HYPOXIA; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; TISSUE OXYGENATION; TUMOR;

ANEMIA; CELL HYPOXIA; ENERGY METABOLISM; GLUCOSE; HUMANS; MITOCHONDRIA; NEOPLASMS; OXYGEN CONSUMPTION; REGIONAL BLOOD FLOW;

EID: 0029994483     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Vaapel P, Kallinowski F, Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465, 1989.
2. Zuaker S: Anemia in Cancer. Cancer Investigation 3(3): 249-260, 1875.
3. Steinberg D: Anemia and Cancer. CA 39(5): 296-304, 1989.
4. Waaburg O: The Metabolism of Tumors. London, Constable & Co. 1 930.
5. Frayer JP and Sutherland RM: A Reduction in the In Situ Rates of Oxygen and Glucose Consumption of Cells in EMT6/Ro Spheroids During Growth. Journal of Cellular Physiology 124: 516-521, 1985.
6. Loagren B and Hellstrand P: Functional role of glycolysis in rat portal vein Acta Physiol Scand 129: 211-219, 1987.
7. Lynch RM and Paul RJ: Energy Metabolism and transduction in smooth muscle Experimentia 41: 970-977, 1985.
8. Freyer JP: Rates of Oxygen Consumption for Proliferating and Quiescent Cells Isolated from Multicellular Tumor Spheroids. Adv Exp Med Biol 345: 335-342, 1994.
9. Kaalinowski F, Mueller-Klieser W, and Vaupel P: Growth-related changes of oxygen consumption rates of tumor cells grown in vitro and in vivo. Journal of Cellular Physiology 138: 183-191, 1989.
10. Zeaan EM, Calkins DP, Cline JM, Thrall DE, Raleigh JA: The relationship between proliferative and oxygenation status in spontaneous canine tumors. Int J Radiation Oncology Biol Phys 27: 891-898, 1993.
11. Hlatky L, Sachs RK, Ring CS: Reducing the hypoxic fraction of a tumor model by growth in low glucose. Br. J. Cancer 59(3): 375-380, 1989.
12. Esaey CJ, Koretsky AP, Domach MM, Jain RK: Role of oxygen vs. glucose in energy metabolism in a mammary carcinoma perfused ex vivo: direct measurement by 31p NMR. Proc Natl Acad Sci USA 90: 2646-2650, 1993.
13. Caaafoli E: Mitochondrial Pathology: An overview. Ann NY Acad Sci 486: 1-18, 1986.
14. Peaerson PL: Tumor mitochondria and the bioenergetics of cancer cells. IN: Progress in experimental tumor research, Vol. 22, Karger, Basel, 1978, pps 190-274.
15. Laaoue KF, Hemington JG, Ohnishi T, Morris HP and Williamson JR: Defects in anion and electron transport in Morris hepatoma mitochondria. In. Hormones and Caacer New York, Academic press 1977.
16. Argiles JM and Lopez-Soriano FJ: Why do cancer cells have such a high glycolytic rate? Medical Hypotheses 32: 151-155, 1990.
17. Bustamante E and Pederson PL: High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase. Proc Natl Acad Sci USA 74(9): 3735-3739, 1977.
18. Raaker E: Why do tumor cells have a high aerobic glycolysis? J Cell Physiol 89: 697-700, 1976.
19. Newsholme EA, and Crabtree B: Theoretical principles in the approaches to control of metabolic pathways and their application to glycolysis in muscle. J Mol Cel Cardiol 11: 839-856, 1979.
20. Arailes JM and Azcon-Bieto J: The metabolic environment of cancer. Mol Cell Bioch. 81: 3-17, 1988.
21. Neasholme EA, Crabtree B and Ardawi MSM: The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Bioscience Reports 5: 393-400, 1985.
22. Haasford RG, and Lehninger AL: Active oxidative decarboxylation of malate by mitochondria isolated from L-1210 ascites tumor cells. Biochem Biophys Res Commun 57: 480-486, 1973.
23. Duaand RE: Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. Int J Radiation Oncology Biol Phys 20: 253-258, 1991.
24. Kaalinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, Okuneiff P, Vaupel P: Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res 49: 3759-3764, 1989.
25. Deaner F, Acker H and Pietruschka F: The Possible Linkage Between Tumor Cell Metabolism and Tumor Cell Growth in Multicellular Spheroids, Adv Exp Med Biol 200: 555-564, 1986.
26. Leeper DB, Engin K, Thistlewaite AJ, Hitchon HD, Dover JD, Li D, Tupchong L: Human tumor extracellular pH as a function of blood glucose concentration. Int J Radiation Oncology Biol Phys 28(4): 935-943, 1994.
27. Jaan RK: Determinants of Tumor Blood Flow: A Review. Cancer Res 48: 2641-2658, 1988.
28. Peaers W, Teixeira M, Intaglietta M, and Gross JF: Microcirculatory studies in rat mammary carcinoma. I. Transparent chamber method, development of microvasculature and prassures in tumor vessels. JNCI 65: 631-642, 1980.
29. Shabik P: Vascularization of tumors: a review. J Cancer Res Clin Oncol 103: 211-226, 1982.
30. Paaletz N and Knieria M: Tumor related angiogenesis. Crit Rev Hematol Oncol 9: 197-242, 1989.
31. Deahirst MW: Angiogenesis and blood flow in solid tumors. In: Drug resistance in oncology (Teicher BA ed.) Marcel Dekker: New York 1993. pp. 3-24.
32. Foatz RM, McLendon RE, Friedman HS, Dodge RK, Bigner DD, Dewhirst MW: A pial window model for the intracranial study of human glioma microvascular function. Neurosurgery 36: 976-985, 1995.
33. Awaad HK, Naggar M, Mocktar N and Barsoum M: Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. Int J Radiation Oncology Biol Phys 12: 1329-1333, 1986.
34. Weadner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis-Correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
35. Leas JR, Skalak TC, Sevick EM, Jain RK: Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 51: 265-273, 1991.
36. Boacher Y, Baxter LT and Jain RK: Interstitial Pressure Gradients in Tissue-isolated and Subcutaneous Tumors: Implications for Therapy. Cancer Res 50: 4478-4484, 1990.
37. Boacher Y and Jain RK: Microvascular Pressure Is the Principal Driving Force for Interstitial Hypertension in Solid Tumors: Implications for Vascular Collapse. Cancer Res 52: 5110-5114, 1992.
38. Baater LT and Jain RK: Transport of Fluid and Macromolecules in Tumors II. Role of Heterogeneous Perfusion and Lyaphatics. Microvas Res 40: 246-263, 1990.
39. Hlamas DE and Gillette EL: Microvasculature of C3H/Bi mouse mammary tumors after X-irradiation. Radiation Research 61: 128-143, 1975.
40. Deahirst MW, Oliver R, Tso CY, Gustafson C, Secomb T, and Gross JF: Heterogeneity in tumor microvascular response to radiation. Int J Radiation Oncology Biol Phys 18: 559-568, 1990.
41. Chaplin DJ, Olive PL and Durand RE: Intermittent blood flow in a murine tumor; radiobiological effects. Cancer Res 47: 597-601, 1987.
42. Chaplin DJ and Trotter MJ: Chemical modifiers of tumour blood flow. In: Tumor blood supply and meaabolic microenvironment: characterization and implications for therapy. (Vaupel P and Jain RK, eds.) Mainz, Akademie der Wissenschaften und der Literatur, (1991), pp. 65-85.
43. Deahirst MW, Vinuya RZ, Ong ET, Klitzman B, Rosner G, Secomb TW and Gross JF: Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature. Radiation Res 130: 345-354, 1992.
44. Guaton AC: Textbook of medical physiology, eighth ed., Philadelphia PA, W. B. Saunders Co. 1991, pp.436-439.
45. Mualler-Klieser W, Vaupel P, Manz R, and Grunewald WA: Intracapillary Oxyhemoglobin Saturation in Malignant Tumors with Central or Peripheral Blood Supply. Europ J Cancer 16: 195-207, 1980.
46. Mualler-Klieser W, Vaupel P, Manz R, Schmidseder R: Intracapillary Oxyhemoglobin Saturation of Malignant Tumors in Humans. Int J Radiation Oncology Biol Phys 7: 1397-1404, 1981.
47. Vaapel P, Manz R, Mueller-Klieser W, and Grunewald WA: Intracapillary HbO2 Saturation in Malignant Tumors during Normoxia and Hyperoxia. Microvascular Research 17: 181-191, 1979.
48. Graenwald WA, and Luebbers DW: Cryophotometry as a method for analyzing the intercapillary HbO2 saturation of organs under different Γ2 supply conditions. Adv Exp Med Biol 75: 55-64, 1976.
49. Suaherland RM: Cell and Environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177-184, 1988.
50. Maatin GR, Jain RK: Fluorescence ratio imaging measurements of pH gradients: calibration and application in normal and tumor tissues. Microvascular Research 46(2): 216-230, 1993.
51. Maatin GR, Jain RK: Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res 54(21): 5670-5674, 1994.
52. Deahirst MW, Secomb TW, Ong ET, Hsu R, Gross JF: Determination of local oxygen consumption rates in tumors. Cancer Res 54: 3333-3336, 1994.
53. Seaick EM and Jain RK: Effect of red blood cell rigidity on tumor blood flow: increase in viscous resistance during hyperglycemia. Cancer Res 51: 2727-2730, 1991.
54. Kaaanaugh BD, Coffey BE, Needham D, Hochmuth RM and Dewhirst MW: The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH and lactate treatment. Br J Cancer 67: 734-741, 1993.
55. Deahirst MW, Ong ET, Madwed D, Klitzman B, Secomb T, Brizel D, Bonaventura J, Rosner G, Kavanagh B, Edwards J, and Gross J: Effects of the Calcium Channel Blocker Flunarizine on the Hemodynamics and Oxygenation of Tumor Microvasculature. Radiation Res 132: 61-68, 1992.
56. Waad-Hartley KA and Jain RK: Effect of Glucose and Galactose on Microcirculatory Flow in Normal and Neoplastic Tissues in Rabbits. Cancer Res 47: 371-377, 1987.
57. Hial RP, Bush RS, and Yeung P: The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. British Journal of Radiology 41: 299-304, 1971.
58. Hiast DG, Hazlehurst JL, Brown JM: The effect of alterations in haematocrit on tumor sensitivity to X-rays. Int J Radiat Biol 46(4): 345-354, 1984.
59. Hiast DG: What is the importance of anaemia in radiotherapy? The value of animal studies. Radiotherapy and Onaology Suppl. 20: 29-33, 1991.
60. Heak JM, Kunkler PB, Smith CW: Radiotherapy and Hyperbaric Oxygen in head and neck cancer. Final report of the first controlled clinical trial. Lancet 2(8029): 101-103, 1977.
61. Kaap DS, Fischer D, Gutierrez E, Kohorn El, Schwartz PE: Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology, and blood counts on survival. Int J Radiation Oncology Biol Phys 9: 445-455, 1983.
62. Deaner FL and Sutherland RM: Theoretical Evaluation of Expected Changes in Oxygenation of Tumors Associated with Different Hemoglobin Levels. Int J Radiation Oncology Biol Phys 12: 1291-1294, 1986.
63. Deaner FL and Sutherland RM: Mathematical Modelling of Supply and Oxygenation in Tumor tissues: Prognostic, Theraputic and Experimental Implications. Int J Radiation Oncology Biol Phys 15: 391-397, 1988.
64. Praes AR, Fritzsche A, Ley K, Gaehtgens P: Redistribution of Red Blood Cell Flow in Microcirculatory Networks by Hemodilution. Circulation Research 70: 1113-1121, 1992.
65. Graebe K and Vaupel P: Evaluation of Oxygen Diffusion Distances in Human Breast Cancer Xenografts Using Tumor-specific in vivo Data: Role of Various Mechanisms in the Developement of Tumor Hypoxia. Int J Radiation Oncology Biol Phys 15: 691-697, 1988.
66. Vaapel P, Kallinowski F and Groebe K: Evaluation of Oxygen Diffusion Distances in Human Breast Cancer Using Cell Line Specific in vivo Data: Role of Various Pathogenetic Mechanisms in the Developement of Tumor Hypoxia. Adv Exp Med Biol 222: 719-726, 1988.
67. Seaomb TW, Hsu R, Dewhirst MW, Klitzman B, Gross JF: Analysis of oxygen transport to tumor tissue by microvascular networks. Int J Radiation Oncology Biol Phys 25: 481-489, 1993.
68. Seaomb TW, Hsu R, Ong ET, Gross JF, Dewhirst MW: Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncologica 34: 313-316, 1995.